Bio and Beyond

We launched an abnormally fast source of emergency science funding during COVID-19. The results revealed the strength and weakness in current funding models.

Which bio companies will have the greatest impact and scale? Which business models will endure the test of time? In short, those that "Compete or Connect"!

It's easy to think extinction equals failure, but in fact, past life may encode the solutions to our most pressing future problems.

One possible solution to the replication crisis is to apply big data, "omics"-like approaches to the scientific literature: aka Publomics.

AI can revolutionize healthcare and the life sciences. But the reality, in practice, is that the potential of AI will be limited — unless it gets a lot smarter.

To harness the untapped power of subtraction in the future, we need to understand why we haven’t embraced it in the past.